MUTANT HIGH GRADE GLIOMA

Clinical trials for MUTANT HIGH GRADE GLIOMA explained in plain language.

Never miss a new study

Get alerted when new MUTANT HIGH GRADE GLIOMA trials appear

Sign up with your email to follow new studies for MUTANT HIGH GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Targeted drug trial offers hope for aggressive brain cancer recurrence

Disease control Completed

This study tested whether the drug olaparib could help control recurrent high-grade brain tumors that have a specific genetic change called an IDH mutation. The trial involved 35 adults in France whose brain cancer had returned after standard treatments like radiation and chemoth…

Matched conditions: MUTANT HIGH GRADE GLIOMA

Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

MUTANT HIGH GRADE GLIOMA

Get alerted when new MUTANT HIGH GRADE GLIOMA trials appear

Targeted drug trial offers hope for aggressive brain cancer recurrence